It takes time for everyone to appreciate their bodies. There are no ways around it. If you live on Earth, at some point you’ve been forced to adjust to these forever-evolving physical landscapes. From unique muscular builds to facial hair and cycles to get in tune with — these are all things we must adjust to.
Eventually, we learn to meet the needs of these ever-changing bodies. We soon become captains who have navigated our shifting shapes, developing a more even-keeled relationship with our physiques. The plot twist is that, over time, we can become complacent and ignore the subtle signs our bodies send us.
This allows precious time to sail by when we should be checking in. Instead, we wait until the last minute and lean into a full diagnostic when those subtle signs turn into an all-hands-on-deck situation.
So when it comes to some of life’s unexpected challenges — like breast cancer — it’s crucial to reclaim our time and lean into care that’s informed and proactive. Kisqali has long supported patients with metastatic breast cancer and, more recently, has become an option for early breast cancer—offering data-driven results that help reduce the risk of cancer returning.
Through targeted therapy approaches like these, patients and providers alike have seen measurable progress — with studies showing that when certain treatments are used in combination with an aromatase inhibitor (AI), 91% of patients remained cancer-free after three years. Those numbers speak to advancement — and to the importance of understanding evolving options in breast cancer care.
It’s worth emphasizing that early detection still offers the greatest chance for positive outcomes. But as we continue learning to listen more closely to our bodies, innovations in treatment and awareness help ensure that more people have access to the knowledge, support, and care they deserve.
Content was independently created by EBONY with funding from Novartis Pharmaceuticals Corp.